Drug Profile
H1N1 pandemic influenza virus vaccine - Sinovac Biotech
Alternative Names: Influenza A (H1N1) vaccine - Sinovac Biotech; Panflu.1; Swine flu vaccine - Sinovac BiotechLatest Information Update: 24 Mar 2015
Price :
$50
*
At a glance
- Originator Sinovac Biotech
- Class Influenza A virus H1N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza A virus H1N1 subtype
Most Recent Events
- 30 Mar 2010 H1N1 vaccine licensed to Parenteral Drugs Ltd in India
- 30 Mar 2010 Preregistration for Influenza-A virus H1N1 subtype in India (IM)
- 17 Nov 2009 The State Food and Drug Administration approves Panflu.1 for use in elderly patients aged > 60 years for prevention of Influenza-A virus H1N1 subtype in China